MSB 4.69% $1.45 mesoblast limited

2023 Next Steps, page-98

  1. 4,202 Posts.
    lightbulb Created with Sketch. 5498
    Well..
    Who to believe.... Doc Mcstuffins who must also therefore think there is a lawsuit coming, because the company has never indicated that this trial would be " very likely" to fail to find significant effect.

    If fact

    I believe Si said, they planned the trial, in adults, with high MAP, based on analysis of the previous falied trial that did show good evidence of effect. So good that the adult trial population would not need to be that large to have significance.

    Doc Mcnuffins is basically talking 180 degrees out from what Si said on the last webcast ..... Lawsuit for Doc or for Si ?

    Based on that, it is very likely that whatever Si says, you as a non holder are going to tout the complete opposite as likely to occur..... keep loading up those short shares though!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.